Home ›
Trademark Categories ›
Pharmaceuticals ›
2022 ›
WE ›
WEZENLA
Trademark search for:
WEZENLA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2022-03-15 — Application filed
2022-03-18 — Application filed
2022-03-21 — Application filed
2022-12-14 — Assigned to examiner
2022-12-21 — Final disposition recorded
2022-12-21 — Final disposition recorded
2022-12-21 — Final disposition recorded
2023-02-20 — Office action issued
2023-02-20 — Correspondence received in law office
2023-02-21 — Teas/email correspondence entered
2023-02-28 — Approved for pub - principal register
2023-03-15 — Notification of notice of publication e-mailed
2023-04-04 — Published for opposition
2023-04-04 — Official gazette publication confirmation e-mailed
2023-05-30 — Noa e-mailed - sou required from applicant
2023-10-02 — Sou teas extension received
2023-10-02 — Sou extension 1 filed
2023-10-02 — Sou extension 1 granted
2023-10-04 — Notice of approval of extension request e-mailed
2024-04-12 — Sou teas extension received
2024-04-12 — Sou extension 2 filed
2024-04-12 — Sou extension 2 granted
2024-04-13 — Notice of approval of extension request e-mailed
2025-01-06 — Application abandoned
2025-01-06 — Application abandoned
2025-01-06 — Final status recorded
Owner Information
Amgen Inc.
Amgen Inc.
Correspondent
Elsa D. Lemoine AMGEN INC.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
